1. Home
  2. LTRN vs GDTC Comparison

LTRN vs GDTC Comparison

Compare LTRN & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • GDTC
  • Stock Information
  • Founded
  • LTRN 2013
  • GDTC 2018
  • Country
  • LTRN United States
  • GDTC Singapore
  • Employees
  • LTRN N/A
  • GDTC N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LTRN Health Care
  • GDTC Health Care
  • Exchange
  • LTRN Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • LTRN 33.7M
  • GDTC 29.4M
  • IPO Year
  • LTRN 2020
  • GDTC 2023
  • Fundamental
  • Price
  • LTRN $4.81
  • GDTC $2.65
  • Analyst Decision
  • LTRN Hold
  • GDTC Buy
  • Analyst Count
  • LTRN 1
  • GDTC 1
  • Target Price
  • LTRN N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • LTRN 163.3K
  • GDTC 25.0K
  • Earning Date
  • LTRN 03-17-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • LTRN N/A
  • GDTC N/A
  • EPS Growth
  • LTRN N/A
  • GDTC N/A
  • EPS
  • LTRN N/A
  • GDTC N/A
  • Revenue
  • LTRN N/A
  • GDTC $330,254.00
  • Revenue This Year
  • LTRN N/A
  • GDTC $14.71
  • Revenue Next Year
  • LTRN N/A
  • GDTC N/A
  • P/E Ratio
  • LTRN N/A
  • GDTC N/A
  • Revenue Growth
  • LTRN N/A
  • GDTC N/A
  • 52 Week Low
  • LTRN $2.79
  • GDTC $1.20
  • 52 Week High
  • LTRN $11.99
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 55.42
  • GDTC 49.22
  • Support Level
  • LTRN $4.60
  • GDTC $2.55
  • Resistance Level
  • LTRN $5.70
  • GDTC $2.94
  • Average True Range (ATR)
  • LTRN 0.64
  • GDTC 0.22
  • MACD
  • LTRN -0.02
  • GDTC 0.01
  • Stochastic Oscillator
  • LTRN 33.54
  • GDTC 53.23

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: